Argenx
ARGX
#531
Rank
$37.80 B
Marketcap
$622.15
Share price
-0.07%
Change (1 day)
59.39%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$4.16

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$4.16. In 2022 the company made an earnings per share (EPS) of -$13.12.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.16-68.29%
2022-$13.12